2021 PDA Pharmaceutical Lyophilization Conference

Online
Ask a Question Exhibitor Standard Contract Clause
Program Highlights

The Final Agenda is out now!

See all the Speakers by clicking the tab above, read up on them and think of some good questions to ask during live Q&As!

Only a few weeks to go, stay tuned or sign up today to not miss out!

Dear Colleague, 

We warmly invite you to join this year's edition of the PDA Pharmaceutical Lyophilization Conference!

Check out an exciting agenda presenting highlights coming from academic research as well as the latest in industry applications and manufacturing developments.

This event will be presented jointly on one virtual conference platform with the 2021 PDA BioManufacturing Conference, making it an overall three-track, two conferences event!

Join us online and don't miss this very special 2-for-1 offer

We look forward to meeting you online in September!

Sincerely,

The Chairs

Raf De Dier, PhD
Janssen J&J

Anthony Cannon, 
MSD

More information coming soon.

ALL PRICES IN EURO (EUR), EXCLUDING VAT.

WAYS TO REGISTER: 1. Online Registration   2. [email protected]

PDA MEMBERS: Please remember to log in before registering If you come from a Governmental or Health Authority Institution or from an Academic Organization, please contact [email protected] before registering.

If you need to apply for a visa to enter the event country, PDA Europe must be informed of this fact at least 4 weeks before the start of the event.

Day 1

Tuesday, 14 September 2021

Conference Platform Opens: Enjoy our Virtual Exhibition & Poster Session
11:00 - 12:00 CEST

Joint Opening Plenary with the BioManufacturing Conference
12:00-14:45 CEST

Joint Opening Plenary with the BioManufacturing Conference

Moderators:
Raf De Dier, Janssen J&J
Cristiana Campa, GSK Vaccines

Opening Keynote: Reinventing Pharma through Digital and Analytics – where are we today? Alvaro Carpintero, McKinsey
EMA’s Perspective on the SARS-CoV-2 Pandemic: 
Regulatory Procedures, Quality Flexibilities, and Future Directions
Ragini Shivji, EMA
The EMA Acceleration Toolkit Mats Welin, Swedish Medicines Agency
The Annex 1 Revision and the Impact on Biomanufacturing Processes Yves Mayeresse, GSK Vaccines,
Jörg Lümkemann, F. Hoffmann-La Roche
Speed to Clinic and How Different Functions Interact to Make it Happen Matthieu Stettler, LONZA

Live Q & A, Panel Discussion


Break, Virtual Exhibition & Poster Session

14:45-15:45 CEST

Module I: Lyophilized Drug Product: Handling and Stability Considerations
15:45-16:55 CEST

Lyophilized Drug Product: Handling and Stability Considerations

Moderators:
Sabine Hauck, Leukocare
Sebastian Groёl,
Ludwig-Maximilians-University, LMU

Preventing Oxidation of a Lyophilized Monoclonal Antibody by Smart Polymer Packaging Nicole Härdter, LMU
Suitability of Intended Use Testing Based on a Simulated Lyophilized Drug Product Diego A Zurbriggen, WEST Pharmaceutical Services
Co-Lyophilization of Reteplase and Dornase Alfa with Arginine Hydrochloride and Tranexamic Acid Magdalena Puttnies, LMU

Live Q & A, Discussion


Module II: Simulation & Modeling

16:55-18:30 CEST

Simulation & Modeling

Moderators:
Sabine Hauck, Leukocare
Yves Mayeresse, GSK Vaccines

Studying the Effects of Process Parameters on the Primary Drying Phase of a Freeze-Drying Cycle Model for a Vaccine Vial: A Hybrid Modelling Approach Md Meraj Khalid, Aligarh Muslim University
SNOWFALL: A Stochastic Shelf-Scale Modeling Framework for the Freezing Stage in Freeze-Drying Leif-Thore Deck, Swiss Technical Academy ETH Zurich
Pore Scale Studies of Lyophilization Based on In-Situ Visualization and Pore Network Modeling Maximilian Thomik, Otto-von-Guericke University

Live Q & A, Discussion


End of Conference Day 1

Interactive Vaccines Interest Group Meeting 
18:30 - 20:00 CEST

Agenda is subject to change without notice.

Day 2

Wednesday, 15 September 2021

Interactive Poster Session: Engage in a live Q&A opportunity with our Poster Presenters in a separate video chat room!
10:00 – 11:30 CEST

Break, Virtual Exhibition & Poster Session
11:30 - 12:00 CEST

Module III: Process Control, Process Development, and Process Environment
12:00 - 13:45 CEST

Process Control, Process Development, and Process Environment

Moderators:
Anthony Cannon, MSD
Sascha Pfeiffer,
Pharmbiocon

Infrared Imaging: A Powerful Non-Invasive Tool for Freeze-Drying Monitoring and Optimization Maite Harguindeguy, Politecnico di Torino
Quality Control and Process Optimization Using Near-Infrared Spectroscopy in Freeze-Drying of Pharmaceutical Products Serena Bobba, Merck Serono
Driving Quality, Traceability, and Production Efficiency by Using “Unique Containers” in Lyophilization R. Tod Urquhart, Eagas

Live Q & A, Discussion

Break, Virtual Exhibition & Poster Session
13:45 - 14:30 CEST

Module IV: Equipment and Manufacturing Trends
14:30 - 16:10 CEST

Equipment and Manufacturing Trends

Moderators:
Thomas Beutler, GEA
Maik Guttzeit, Bayer

Lyophilizer in Aseptic Production Lines: Challenges and Opportunities Kristien Janssen, Pfizer Manufacturing Belgium
Application of Interventions Risk Evaluation Model (IREM) for Aseptic Processing Involving Lyophilization Subrata Chakraborty, GxPFONT Consulting
Real-Time Analysis of Freeze-Dried Products as an Answer to Today’s Challenges in Vaccine Production Fabien Chauchard, Indatech

Live Q & A, Discussion


Break, Virtual Exhibition & Poster Session
16:10 - 16:40 CEST

Module V: Green Manufacturing / Novel Materials & Methods
16:40 - 18:30 CEST

Green Manufacturing / Novel Materials & Methods
Moderators:
Thomas Frank, Refolution
Thomas Beutler, GEA
Current Developments in Refrigeration Solutions for Lyophilization Thomas Frank, Refolution
Thomas Beutler, GEA
Solvent-Based Products: Taking Freeze-Drying and Recovery to the Next Level Fabian Plaum,
HOF Sonderanlagenbau
Flammable Refrigerants in Lyophilization Georg Gruenwalder,
Roche Diagnostics

Live Q & A, Discussion

LIVE Conference Summaries by the Chairs of the BioManufacturing and the Pharmaceutical Lyophilization Conferences

Cristiana Campa, GSK Vaccines
Michael De Felippis, Eli Lilly & Company
Raf De Dier, Janssen J&J
Anthony Cannon, MSD

Thank You Remarks and Farewell Falk Klar, PDA Europe


Agenda is subject to change without notice.

PLEASE READ  PDA is not affiliated or contracted with any outside hotel contracting company. If someone other than PDA or the PDA chosen hotel contacts you suggesting that they represent any PDA event, they do not. It is PDA's recommendation that you book your hotel directly through the official PDA chosen hotel that is listed on our web site.